Proteinuria and decreased body mass index as a significant risk factor in developing end-stage renal disease

[1]  T. Greene,et al.  Relationship between nutritional status and the glomerular filtration rate: results from the MDRD study. , 2000, Kidney international.

[2]  Carlos Iribarren,et al.  Body Mass Index and Risk for End-Stage Renal Disease , 2006, Annals of Internal Medicine.

[3]  J. Sowers.  Metabolic risk factors and renal disease. , 2007, Kidney international.

[4]  K. Johansen,et al.  The enlarging body of evidence: obesity and chronic kidney disease. , 2006, Journal of the American Society of Nephrology : JASN.

[5]  K. Iseki,et al.  Demographic trends in the Okinawa Dialysis Study (OKIDS) registry (1971-2000). , 2002, Kidney international.

[6]  Robert M Califf,et al.  Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. , 2004, The New England journal of medicine.

[7]  B. Brenner,et al.  Albuminuria is a target for renoprotective therapy independent from blood pressure in patients with type 2 diabetic nephropathy: post hoc analysis from the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial. , 2007, Journal of the American Society of Nephrology : JASN.

[8]  Ethan M Balk,et al.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[9]  A. Luke,et al.  Increasing body mass index and obesity in the incident ESRD population. , 2006, Journal of the American Society of Nephrology : JASN.

[10]  L. Ruilope,et al.  Effects of body-weight loss and captopril treatment on proteinuria associated with obesity. , 1995, Nephron.

[11]  F. Irie,et al.  The relationships of proteinuria, serum creatinine, glomerular filtration rate with cardiovascular disease mortality in Japanese general population. , 2006, Kidney international.

[12]  P. Metcalf,et al.  Albuminuria in people at least 40 years old: effect of obesity, hypertension, and hyperlipidemia. , 1992, Clinical chemistry.

[13]  K. Iseki,et al.  Changes in the Demographics and Prevalence of Chronic Kidney Disease in Okinawa, Japan (1993 to 2003) , 2007, Hypertension Research.

[14]  Tom Greene,et al.  Using Standardized Serum Creatinine Values in the Modification of Diet in Renal Disease Study Equation for Estimating Glomerular Filtration Rate , 2006, Annals of Internal Medicine.

[15]  S. Bakker,et al.  Metabolic aspects of dietary sodium restriction as a therapeutic intervention , 2010 .

[16]  M. Tonelli,et al.  Progression of kidney dysfunction in the community-dwelling elderly. , 2006, Kidney international.

[17]  Jing Chen,et al.  The Metabolic Syndrome and Chronic Kidney Disease in U.S. Adults , 2004, Annals of Internal Medicine.

[18]  Joseph K McLaughlin,et al.  Obesity and risk for chronic renal failure. , 2006, Journal of the American Society of Nephrology : JASN.

[19]  A. Brookes,et al.  Direct microdissection and microcloning of a translocation breakpoint region, t(1;11)(q42.2;q21), associated with schizophrenia. , 1995, Cytogenetics and Cell Genetics.

[20]  E. Finkelstein,et al.  The economics of obesity. , 2010, The American journal of clinical nutrition.

[21]  K. Iseki,et al.  Metabolic syndrome and chronic kidney disease in Okinawa, Japan. , 2006, Kidney international.

[22]  K. Iseki,et al.  Body mass index and the risk of development of end-stage renal disease in a screened cohort. , 2004, Kidney international.

[23]  G. Chertow,et al.  The metabolic syndrome and chronic kidney disease , 2006, Current opinion in nephrology and hypertension.

[24]  M. Kubo,et al.  Chronic kidney disease and cardiovascular disease in a general Japanese population: the Hisayama Study. , 2005, Kidney international.

[25]  K. Flegal,et al.  Epidemiologic trends in overweight and obesity. , 2003, Endocrinology and metabolism clinics of North America.

[26]  Neil R. Powe,et al.  Lifestyle Factors, Obesity and the Risk of Chronic Kidney Disease , 2003, Epidemiology.

[27]  T. Yipintsoi,et al.  Risk factors for development of decreased kidney function in a southeast Asian population: a 12-year cohort study. , 2005, Journal of the American Society of Nephrology : JASN.

[28]  K. Iseki,et al.  Influence of smoking and obesity on the development of proteinuria. , 2002, Kidney international.

[29]  V. D’Agati,et al.  Obesity-related glomerulopathy: an emerging epidemic. , 2001, Kidney international.

[30]  B. Eriksen,et al.  The progression of chronic kidney disease: a 10-year population-based study of the effects of gender and age. , 2006, Kidney international.

[31]  K. Iseki.  The okinawa screening program. , 2003, Journal of the American Society of Nephrology : JASN.

[32]  S. Ito,et al.  Estimation of glomerular filtration rate by the MDRD study equation modified for Japanese patients with chronic kidney disease , 2007, Clinical and Experimental Nephrology.

[33]  G. Chertow,et al.  Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. , 2005, Journal of the American Society of Nephrology : JASN.

[34]  K. Iseki,et al.  Risk of developing end-stage renal disease in a cohort of mass screening. , 1996, Kidney international.

[35]  Daniel Levy,et al.  Predictors of new-onset kidney disease in a community-based population. , 2004, JAMA.

[36]  G. Remuzzi,et al.  How does proteinuria cause progressive renal damage? , 2006, Journal of the American Society of Nephrology : JASN.

[37]  K. Iseki,et al.  Risk of Developing Low Glomerular Filtration Rate or Elevated Serum Creatinine in a Screened Cohort in Okinawa, Japan , 2007, Hypertension Research.